IP Library Granted Patent US 12,662,681
Granted Patent B2
US 12,662,681 · App. 18/587,120 · Granted Jun 23, 2026

Multi-pulse transfection methods and cells

Inventors: Marcos Sixto (Culver City, CA); Kayvan Niazi (Culver City, CA); Ting Wu (Culver City, CA); Chihwei Chang (Culver City, CA)
Assignee: NantBio, Inc.
C12N15/8206C12N5/10C12N15/85C12N15/87A61K48/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,662,681
App. No.
18/587,120
Granted
Jun 23, 2026
Kind
B2
Abstract

Systems and methods are provided for transfecting immune competent cells with RNA at high efficiency and viability.

Claims (23)

1 . A method of transfecting mammalian cells with a RNA, comprising:

disposing the mammalian cells with the RNA in a transfection medium, wherein the mammalian cells are NK cells;

applying two, three, or four pulses to the mammalian cells at a field strength of 600-1,400 V/cm and a time constant from about 0.5 msec to about 10 msec to produce transfected mammalian cells.

2 . The method of claim 1 , wherein the transfection medium is an isotonic medium and a growth medium or a high conductance medium.

3 . The method of claim 1 , wherein a time between each pulse is between 1-15 seconds.

4 . The method of claim 3 , wherein the time between each pulse is between 2-10 seconds.

5 . The method of claim 1 , wherein the field strength is applied at a gap width of about 0.1 cm to about 0.4 cm.

6 . The method of claim 1 , wherein the time constant is about 0.5 msec to about 5 msec.

7 . The method of claim 1 , wherein the time constant is about 1 msec to about 3 msec.

8 . The method of claim 1 , wherein the field strength is applied at a voltage of between 150-250 V.

9 . The method of claim 1 , wherein the field strength is 800-1200 V/cm.

10 . The method of claim 1 , wherein the pulses are delivered from a capacitor having a capacitance of between 5-50 μF.

11 . The method of claim 1 , wherein the pulses are delivered from a capacitor having a capacitance of between 10-25 μF.

12 . The method of claim 1 , further comprising a step of culturing the transfected mammalian cells after pulsing.

13 . The method of claim 1 , wherein the transfected mammalian cells have a viability of at least 70%.

14 . The method of claim 1 , wherein the pulses provide a transfection efficiency of at least 80%.

15 . The method of claim 1 , wherein an injected charge is between 1 mC and 30 mC.

16 . A method of transfecting mammalian cells with a RNA, comprising:

disposing the mammalian cells with the RNA in a transfection medium, wherein the mammalian cells are NK cells; and

applying two, three, or four pulses to the mammalian cells at a voltage of 150-250 V, a gap width of about 0.1 cm to about 0.4 cm, and a time constant from about 0.5 msec to about 10 msec to produce transfected mammalian cells, wherein the pulses are delivered from a capacitor having a capacitance of between 5-50 μF.

17 . A method of transfecting mammalian cells with a RNA, comprising:

disposing the mammalian cells with the RNA in a transfection medium, wherein the mammalian cells are NK cells; and

applying two, three, or four pulses to the mammalian cells at a field strength of 600-1,400 V/cm and a time constant from about 0.5 msec to about 10 msec to produce transfected mammalian cells, wherein the pulses are delivered from a capacitor having a capacitance of between 5-50 μF.